660 related articles for article (PubMed ID: 23886432)
21. SQ sublingual immunotherapy tablets for children with allergic rhinitis: A review of phase three trials.
Csonka P; Hamelmann E; Turkalj M; Roberts G; Mack DP
Acta Paediatr; 2024 Jun; 113(6):1209-1220. PubMed ID: 38529710
[TBL] [Abstract][Full Text] [Related]
22. How reliable is anamnestic data in predicting the clinical relevance of house dust mite sensitization?
Englhard AS; Holzer M; Eder K; Gellrich D; Gröger M
Eur Arch Otorhinolaryngol; 2022 Feb; 279(2):801-810. PubMed ID: 34019148
[TBL] [Abstract][Full Text] [Related]
23. Circulating T follicular helper 2 cells, T follicular regulatory cells and regulatory B cells are effective biomarkers for predicting the response to house dust mite sublingual immunotherapy in patients with allergic respiratory diseases.
Shigehara K; Kamekura R; Ikegami I; Sakamoto H; Yanagi M; Kamiya S; Kodama K; Asai Y; Miyajima S; Nishikiori H; Uno E; Yamamoto K; Takano K; Chiba H; Ohnishi H; Ichimiya S
Front Immunol; 2023; 14():1284205. PubMed ID: 38111589
[TBL] [Abstract][Full Text] [Related]
24. A clinical index: a new method to assess efficacy of allergen immunotherapy.
McHugh SM; Ewan PW
Allergy; 1992 Apr; 47(2 Pt 1):115-20. PubMed ID: 1632479
[TBL] [Abstract][Full Text] [Related]
25. Effective hyposensitization in allergic rhinitis using a potent partially purified extract of house dust mite.
Ewan PW; Alexander MM; Snape C; Ind PW; Agrell B; Dreborg S
Clin Allergy; 1988 Sep; 18(5):501-8. PubMed ID: 3069238
[TBL] [Abstract][Full Text] [Related]
26. A 12-week DBPC dose-finding study with sublingual monomeric allergoid tablets in house dust mite-allergic patients.
Hüser C; Dieterich P; Singh J; Shah-Hosseini K; Allekotte S; Lehmacher W; Compalati E; Mösges R
Allergy; 2017 Jan; 72(1):77-84. PubMed ID: 27068870
[TBL] [Abstract][Full Text] [Related]
27. RAST in diagnosis and therapy of allergic rhinitis.
Kato S; Nakai Y; Ohashi Y; Kato M
Acta Otolaryngol Suppl; 1991; 486():209-16. PubMed ID: 1842868
[TBL] [Abstract][Full Text] [Related]
28. Subcutaneous Immunotherapy for Allergic Asthma in a Single Center of Korea: Efficacy, Safety, and Clinical Response Predictors.
Lee JH; Kim SC; Choi H; Jung CG; Ban GY; Shin YS; Nahm DH; Park HS; Ye YM
J Korean Med Sci; 2017 Jul; 32(7):1124-1130. PubMed ID: 28581269
[TBL] [Abstract][Full Text] [Related]
29. Subcutaneous immunotherapy with purified Der p1 and 2 suppresses type 2 immunity in a murine asthma model.
Hesse L; van Ieperen N; Habraken C; Petersen AH; Korn S; Smilda T; Goedewaagen B; Ruiters MH; van der Graaf AC; Nawijn MC
Allergy; 2018 Apr; 73(4):862-874. PubMed ID: 29318623
[TBL] [Abstract][Full Text] [Related]
30. [An analysis of skin prick test reactivity to dust mite in overweight and normal weight children with allergic asthma before and after specific immunotherapy].
Wang J; Huang Y; Zhang XL; Huang X; Xu XW; Liang FM
Zhongguo Dang Dai Er Ke Za Zhi; 2016 Apr; 18(4):329-34. PubMed ID: 27097578
[TBL] [Abstract][Full Text] [Related]
31. Epigenetic modifications and improved regulatory T-cell function in subjects undergoing dual sublingual immunotherapy.
Swamy RS; Reshamwala N; Hunter T; Vissamsetti S; Santos CB; Baroody FM; Hwang PH; Hoyte EG; Garcia MA; Nadeau KC
J Allergy Clin Immunol; 2012 Jul; 130(1):215-24.e7. PubMed ID: 22677046
[TBL] [Abstract][Full Text] [Related]
32. Clinical efficacy and safety evaluation of Dermatophagoides farinae drops in the treatment of allergic rhinitis with epistaxis.
Pei J; Ding Z; Cai L; Yang H; Tao Y; Huang C
Eur Ann Allergy Clin Immunol; 2024 May; ():. PubMed ID: 38813925
[No Abstract] [Full Text] [Related]
33. Utility of silver birch and house dust mite extracts derived from licensed sublingual tablets for nasal allergen challenge.
Olivieri B; Gil AJ; Stoenchev K; Durham SR; Scadding G
Clin Transl Allergy; 2024 May; 14(5):e12360. PubMed ID: 38779783
[TBL] [Abstract][Full Text] [Related]
34. A double-blind, multicenter immunotherapy trial in children, using a purified and standardized Cladosporium herbarum preparation. I. Clinical results.
Dreborg S; Agrell B; Foucard T; Kjellman NI; Koivikko A; Nilsson S
Allergy; 1986 Feb; 41(2):131-40. PubMed ID: 3518526
[TBL] [Abstract][Full Text] [Related]
35. Clinical Relevance of Lepidoglyphus destructor Sensitisation in Allergic Rhinitis: Nasal Provocation Test as in vivo Assessment.
Matos Semedo F; Martins C; Tomaz E; Cardoso B; Farinha S; Martins M; Paula Pires A; Inácio F; Taborda-Barata L
Int Arch Allergy Immunol; 2024; 185(5):436-448. PubMed ID: 38266498
[TBL] [Abstract][Full Text] [Related]
36. Sodium Chloride versus Lactose as a Carrier for House Dust Mite Allergen in Allergen Chamber Studies: A Clinical Study to Assess Noninferiority.
Struß N; Dieter S; Schwarz K; Badorrek P; Hohlfeld JM
Int Arch Allergy Immunol; 2023; 184(11):1143-1152. PubMed ID: 37586347
[TBL] [Abstract][Full Text] [Related]
37. House dust mite sublingual allergen immunotherapy tablet is safe and well-tolerated in Dutch clinical practice.
Tempels-Pavlica Ž; Aarts MCJ; Welsing PMJ; van der Meer AN; van der Zwan LP; Uss E; Knulst AC
Front Allergy; 2024; 5():1355324. PubMed ID: 38487467
[TBL] [Abstract][Full Text] [Related]
38. A placebo-controlled trial of immunotherapy with two extracts of Dermatophagoides pteronyssinus in allergic rhinitis, comparing clinical outcome with changes in antigen-specific IgE, IgG, and IgG subclasses.
McHugh SM; Lavelle B; Kemeny DM; Patel S; Ewan PW
J Allergy Clin Immunol; 1990 Oct; 86(4 Pt 1):521-31. PubMed ID: 1699985
[TBL] [Abstract][Full Text] [Related]
39. Specific immunotherapy with a standardized Dermatophagoides pteronyssinus extract. II. Prediction of efficacy of immunotherapy.
Bousquet J; Hejjaoui A; Clauzel AM; Guérin B; Dhivert H; Skassa-Brociek W; Michel FB
J Allergy Clin Immunol; 1988 Dec; 82(6):971-7. PubMed ID: 3204255
[TBL] [Abstract][Full Text] [Related]
40. Allergen specific IgG subclass antibody response in hyposensitization with Dermatophagoides pteronyssinus extract.
Pastorello EA; Incorvaia C; Gerosa A; Vassellatti D; Italia M; Pravettoni V
N Engl Reg Allergy Proc; 1987; 8(6):417-21. PubMed ID: 3481429
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
